AtaiBeckley (ATAI)
3.95
-0.55 (12.22%)
Upcoming Events
Latest Headlines
AtaiBeckley launches $60,000 grant program for mental health nonprofits
May 28, 2026 9:05 AM - StreetInsider
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations
May 28, 2026 9:00 AM - StreetInsider
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
May 27, 2026 6:00 AM - StreetInsider
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
May 12, 2026 8:01 AM - Globe NewsWire
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
April 27, 2026 4:05 AM - StreetInsider
Form 4 AtaiBeckley Inc. For: Apr 20 Filed by: Craig Kevin James
April 22, 2026 5:33 PM - SEC Filing
AtaiBeckley (ATAI) call put ratio 7.3 calls to 1 put with a focus on May calls as share price up 23%
April 20, 2026 3:13 PM - StreetInsider
AtaiBeckley Inc (ATAI) PT Raised to $15 at Canaccord
April 20, 2026 7:37 AM - StreetInsider
Psychedelic drug developers rally after Trump orders FDA to expedite reviews
April 20, 2026 6:43 AM - StreetInsider
Psychedelic stocks soar after Trump signs executive order to fast-track treatments
April 20, 2026 6:08 AM - StreetInsider
AtaiBeckley Inc (ATAI) PT Raised to $16 at Guggenheim
April 17, 2026 8:12 AM - StreetInsider
White House Prepares Order On Ibogaine Psychedelic - CBS
April 16, 2026 11:53 AM - StreetInsider
Form 4 AtaiBeckley Inc. For: Apr 08 Filed by: Apeiron Investment Group Ltd.
April 10, 2026 6:00 PM - SEC Filing
AtaiBeckley drug shows sustained depression response in trial
April 8, 2026 6:00 AM - StreetInsider
AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
April 8, 2026 6:00 AM - Globe NewsWire
Deutsche Bank Starts AtaiBeckley Inc (ATAI) at Buy
March 27, 2026 3:25 AM - StreetInsider
Form 4 AtaiBeckley Inc. For: Mar 20 Filed by: Craig Kevin James
March 24, 2026 6:01 PM - SEC Filing
ATAI added to S&P and CRSP indices with $3 trillion in passive funds
March 24, 2026 6:00 AM - StreetInsider
AtaiBeckley added to S&P and CRSP benchmark indices
March 24, 2026 6:00 AM - StreetInsider
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
March 24, 2026 6:00 AM - Globe NewsWire
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
March 24, 2026 6:00 AM - StreetInsider
Form 144 Atai Beckley N.V. Filed by: Craig Kevin James
March 20, 2026 4:42 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
March 18, 2026 7:58 AM - StreetInsider
AtaiBeckley publishes phase 2a data for depression treatment BPL-003
March 17, 2026 6:00 AM - StreetInsider
BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiati
March 17, 2026 6:00 AM - StreetInsider
Form 4 AtaiBeckley Inc. For: Mar 11 Filed by: Faerm Michael E.
March 13, 2026 5:01 PM - SEC Filing
Form 3 AtaiBeckley Inc. For: Mar 09 Filed by: Faerm Michael E.
March 13, 2026 5:00 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on atai Life Sciences N.V (ATAI)
March 10, 2026 7:23 AM - StreetInsider
AtaiBeckley plans phase 3 trials for depression drug in Q2 2026
March 10, 2026 6:00 AM - StreetInsider
BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
March 10, 2026 6:00 AM - StreetInsider
AtaiBeckley (ATAI) files mixed shelf
March 9, 2026 6:04 AM - StreetInsider
Full Article List
